Marathon Trading Investment Management LLC purchased a new stake in Molina Healthcare, Inc (NYSE:MOH – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 8,705 shares of the company’s stock, valued at approximately $1,511,000.
Several other institutional investors have also recently added to or reduced their stakes in MOH. Torren Management LLC acquired a new position in Molina Healthcare in the fourth quarter valued at approximately $26,000. Miller Global Investments LLC acquired a new position in Molina Healthcare in the fourth quarter valued at approximately $27,000. Cromwell Holdings LLC lifted its stake in Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after buying an additional 125 shares during the period. Quarry LP acquired a new position in Molina Healthcare in the fourth quarter valued at approximately $32,000. Finally, Triumph Capital Management lifted its stake in Molina Healthcare by 4,625.0% in the fourth quarter. Triumph Capital Management now owns 189 shares of the company’s stock valued at $33,000 after buying an additional 185 shares during the period. 98.50% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
MOH has been the topic of a number of research reports. Morgan Stanley upped their target price on Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a research report on Thursday, June 4th. Robert W. Baird upped their target price on Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a research report on Wednesday, April 29th. UBS Group upped their target price on Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, May 22nd. Finally, Cantor Fitzgerald upped their target price on Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Molina Healthcare currently has an average rating of “Hold” and a consensus price target of $182.73.
Insiders Place Their Bets
In related news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This represents a 20.96% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.44% of the company’s stock.
Molina Healthcare Price Performance
Shares of NYSE:MOH opened at $200.55 on Monday. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $311.52. The stock’s 50 day moving average is $174.79 and its 200-day moving average is $164.63. The firm has a market capitalization of $10.45 billion, a price-to-earnings ratio of 59.33 and a beta of 0.80.
Molina Healthcare (NYSE:MOH – Get Free Report) last issued its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. During the same period in the prior year, the firm earned $6.08 earnings per share. Molina Healthcare’s revenue for the quarter was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Sell-side analysts forecast that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.
Molina Healthcare Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Stories
- Five stocks we like better than Molina Healthcare
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
